Baum Charles M's Form 4 filing
Mirati Therapeutics, Inc. (MRTX) · filed Dec 3, 2021
- Accession no.
- 0001214659-21-012712
- Filed
- Dec 3, 2021
- Trade date
- Dec 3, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.29M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baum Charles MCIK 0001579824 | Director, Officer (President & Head of R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Common Stock | MOption exerciseAcquired | +47,204 | $8.49 | +$400,761.96 | 159,918 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −9,200 | $131.61F2 | −$1,210,812 | 150,718 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −21,509 | $132.49F3 | −$2,849,727.41 | 129,209 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −3,900 | $133.27F4 | −$519,753 | 125,309 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −3,842 | $134.57F5 | −$517,017.94 | 121,467 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −6,558 | $135.64F6 | −$889,527.12 | 114,909 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −1,210 | $136.66F7 | −$165,358.6 | 113,699 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −985 | $137.56F8 | −$135,496.6 | 112,714 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Common Stock | MOption exerciseDisposed | −47,204 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $131.07 to $132.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $132.07 to $133.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $133.07 to $134.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $134.15 to $135.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $135.15 to $136.135. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $136.29 to $137.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $137.34 to $137.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.